Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure

The chronic hepatitis C (CHC) treatment is currently based on the use of direct-acting antivirals (DAAs), and patients infected with hepatitis C virus genotype 3 (GT3) have emerged as a more difficult-to-cure population. The NS5A inhibitor daclatasvir (DCV) and sofosbuvir (SOF), an NS5B viral polyme...

Descripción completa

Detalles Bibliográficos

Autores principales:	João Paulo Vilela Rodrigues, Guilherme Rodrigues Fernandes Campos, Cintia Bittar, Ana de Lourdes Candolo Martinelli, Marília Silveira de Almeida Campos, Leonardo Régis Leira Pereira, Paula Rahal, Fernanda Fernandes Souza
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2022-11-01
Colección:	Brazilian Journal of Infectious Diseases
Materias:	Hepatitis C, Chronic Hepacivirus Antiviral agents Drug resistance, Viral
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S141386702200410X
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!